CanSino Biologics Inc. (HKG:6185)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
34.60
+0.30 (0.87%)
Jun 6, 2025, 4:08 PM HKT

CanSino Biologics Revenue

CanSino Biologics had revenue of 137.16M CNY in the quarter ending March 31, 2025, with 20.02% growth. This brings the company's revenue in the last twelve months to 869.22M, up 134.41% year-over-year. In the year 2024, CanSino Biologics had annual revenue of 846.34M with 137.01% growth.

Revenue (ttm)
869.22M CNY
Revenue Growth
+134.41%
P/S Ratio
12.90
Revenue / Employee
786.62K CNY
Employees
1,105
Market Cap
12.02B HKD

Revenue Chart

* This company reports financials in CNY.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024846.34M489.25M137.01%
Dec 31, 2023357.08M-677.51M-65.49%
Dec 31, 20221.03B-3.27B-75.94%
Dec 31, 20214.30B4.27B17,174.82%
Dec 31, 202024.89M22.61M990.05%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro